2002Chinese Journal of Clinical HepatologyRequires access

Preliminary evidence that a hepatitis E virus(HEV)ORF_2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV

Bi Shengli

Open publisher page 0 citations

Abstract

Objective To observe the protective effict of hepatitis E virus(HEV)ORF 2 recombinant protein expressed in prokaryote cell cynomolgus macaques(cynos)against challenging with wild-type HEV.Methods Cynos were immunized with HEV ORF 2 recombinant protein and then challenged with wild-type HEV,the unimmunized cynos were used as control.Blood samples were collected and tested to see if there were dynamic changes of ALT and antibody to HEV before and after challenge with wild-type HEV.Results All the five unimmunized cynos re-presented hepatitis 3 weeks after challenging with wild-type HEV.However,all the five immunized cynos showed no hepatitis and pathological changes.Conclusion Cynos can be efficiently protected by immunization with HEV ORF 2 recombinant protein against wild-type HEV.This protein can be a promising candidate for HEV vaccine.

About this research paper

What this paper is about

Objective To observe the protective effict of hepatitis E virus(HEV)ORF 2 recombinant protein expressed in prokaryote cell cynomolgus macaques(cynos)against challenging with wild-type HEV.Methods Cynos were immunized with HEV ORF 2 recombinant protein and then challenged with wild-type HEV,the unimmunized cynos were used as control.Blood samples were collected and tested to see if there were dynamic changes of ALT and antibody to HEV before and after challenge with wild-type HEV.Results All the five unimmunized cynos re-presented hepatitis 3 weeks after challenging with wild-type HEV.However,all the five immunized cynos showed no hepatitis and pathological changes.Conclusion Cynos can be efficiently protected by immunization with HEV ORF 2 recombinant protein against wild-type HEV.This protein can be a promising candidate for HEV vaccine.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the protective effict of hepatitis E virus(HEV)ORF 2 recombinant protein expressed in prokaryote cell cynomolgus macaques(cynos)against challenging with wild-type HEV.Methods Cynos were immunized with HEV ORF 2 recombinant protein and then challenged with wild-type HEV,the unimmunized cynos were used as control.Blood samples were collected and tested to see if there were dynamic changes of ALT and antibody to HEV before and after challenge with wild-type HEV.Results All the five unimmunized cynos re-presented hepatitis 3 weeks after challenging with wild-type HEV.However,all the five immunized cynos showed no hepatitis and pathological changes.Conclusion Cynos can be efficiently protected by immunization with HEV ORF 2 recombinant protein against wild-type HEV.This protein can be a promising candidate for HEV vaccine.

Key concepts: Hepatitis E virus, Virology, Recombinant DNA, Biology, Hepatitis E, Caliciviridae, Virus, Viral disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Preliminary evidence that a hepatitis E virus(HEV)ORF_2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV — Research Paper | ScholarLens